 |
|
Study suggests new target for treatment of depression
April 29, 2009Disrupting a brain protein produces antidepressant-like effect in mice
A brain protein involved in fear behavior and anxiety may represent a new target for depression therapies, according to a study by researchers at the University of Iowa and the Iowa City Veterans Affairs Medical Center. The results appear in the April 29 issue of the Journal of Neuroscience.
Depression affects at least 14 million American adults and can be severely disabling. However, the causes of depression are not well understood. In addition, up to half of people diagnosed with depression are not helped by current therapies because either the drug is not effective for them, or the side effects are intolerable.
The UI research team found that disrupting ASIC1a -- an ion channel protein found in the brain -- produced an antidepressant-like effect in mice. The effect was similar to that produced by currently available antidepressant drugs, but the team also showed that ASIC1a's effect arose through a new and different biological mechanism.
"The mechanism issue is important because if a patient doesn't respond to one drug, the chances of them responding to another drug that works through the same mechanism are low," said study investigator John Wemmie, M.D., Ph.D., associate professor of psychiatry and neurosurgery at the UI Carver College of Medicine and a staff physician and researcher at the Iowa City Veterans Affairs Medical Center. "We need antidepressants with new mechanisms of action to help those people who don't respond to what is currently available."
Wemmie added that although there is no immediate therapy available based on the new findings, the results suggest that ASIC1a inhibition represents a new approach to antidepressant therapy. The channel can be blocked pharmacologically. In addition, manipulating brain pH (a measure of acidity) might be used to inhibit this ion channel, which is activated by acid (low pH).
The study also indicated that using antidepressant drugs and inhibiting ASIC1a at the same time produced an additive effect in mice, suggesting that ASIC1a inhibition used in conjunction with current medications might boost antidepressant effects in patients.
The researchers focused on ASIC1a because recent studies have pointed to a role for this ion channel in depression. In particular, previous animal studies from Wemmie's lab showed that ASIC1a plays an important role in fear responses (panic) and anxiety, conditions that often accompany depression. Other research has suggested a strong relationship between anxiety, depression and the brain's fear circuitry, including the amygdala, where ASIC1a is abundant.
In their latest study, Wemmie's team used experiments targeting the amygdala to show that this brain region is a key site of action for ASIC1a's antidepressant effect. The results support the idea that depression may be caused, at least in part, by abnormal amygdala activity.
"Because the ASIC1a protein is especially abundant in areas of the brain that regulate emotion, it is possible that interventions targeting ASIC1a could treat depression while having fewer effects on other brain areas and thus fewer side effects than available treatments. But much more work is needed to determine if this approach can be used therapeutically," said Matthew Coryell, Ph.D., lead study author and a recent graduate of the UI Neuroscience Program.
The researchers also found that ASIC1a function might underlie the connection between stress and depression. Stress can precipitate depression, and research from other labs has suggested this might be because stress lowers levels of protective brain hormones called neurotrophic factors. The UI team found that removing ASIC1a prevented stress from reducing levels of one neurotrophic factor called BDNF in mice. The findings might mean that inhibiting ASIC1a could increase the brain's ability to resist the negative effects of stress and perhaps reduce a person's likelihood of developing depression.
University of Iowa
The UI research team found that disrupting ASIC1a -- an ion channel protein found in the brain -- produced an antidepressant-like effect in mice. The effect was similar to that produced by currently available antidepressant drugs, but the team also showed that ASIC1a's effect arose through a new and different biological mechanism.
"The mechanism issue is important because if a patient doesn't respond to one drug, the chances of them responding to another drug that works through the same mechanism are low," said study investigator John Wemmie, M.D., Ph.D., associate professor of psychiatry and neurosurgery at the UI Carver College of Medicine and a staff physician and researcher at the Iowa City Veterans Affairs Medical Center. "We need antidepressants with new mechanisms of action to help those people who don't respond to what is currently available."
Wemmie added that although there is no immediate therapy available based on the new findings, the results suggest that ASIC1a inhibition represents a new approach to antidepressant therapy. The channel can be blocked pharmacologically. In addition, manipulating brain pH (a measure of acidity) might be used to inhibit this ion channel, which is activated by acid (low pH).
The study also indicated that using antidepressant drugs and inhibiting ASIC1a at the same time produced an additive effect in mice, suggesting that ASIC1a inhibition used in conjunction with current medications might boost antidepressant effects in patients.
The researchers focused on ASIC1a because recent studies have pointed to a role for this ion channel in depression. In particular, previous animal studies from Wemmie's lab showed that ASIC1a plays an important role in fear responses (panic) and anxiety, conditions that often accompany depression. Other research has suggested a strong relationship between anxiety, depression and the brain's fear circuitry, including the amygdala, where ASIC1a is abundant.
In their latest study, Wemmie's team used experiments targeting the amygdala to show that this brain region is a key site of action for ASIC1a's antidepressant effect. The results support the idea that depression may be caused, at least in part, by abnormal amygdala activity.
"Because the ASIC1a protein is especially abundant in areas of the brain that regulate emotion, it is possible that interventions targeting ASIC1a could treat depression while having fewer effects on other brain areas and thus fewer side effects than available treatments. But much more work is needed to determine if this approach can be used therapeutically," said Matthew Coryell, Ph.D., lead study author and a recent graduate of the UI Neuroscience Program.
The researchers also found that ASIC1a function might underlie the connection between stress and depression. Stress can precipitate depression, and research from other labs has suggested this might be because stress lowers levels of protective brain hormones called neurotrophic factors. The UI team found that removing ASIC1a prevented stress from reducing levels of one neurotrophic factor called BDNF in mice. The findings might mean that inhibiting ASIC1a could increase the brain's ability to resist the negative effects of stress and perhaps reduce a person's likelihood of developing depression.
University of Iowa
Depression Current Events and Depression News RSSBurnout and mental distress strongly related to errors by US surgeons
Major medical errors self-reported by American surgeons are strongly related to both burnout and depression. Those findings appear today in the online edition of Annals of Surgery. The Mayo Clinic-led study included collaborators from Johns Hopkins and the American College of Surgeons.
Mother's Depression a Risk Factor in Childhood Asthma Symptoms, Study Suggests
Asthma symptoms can worsen in children with depressed mothers, according to research from Johns Hopkins Children's Center published online in the Journal of Pediatric Psychology.
Dispensing prescription drugs in 3-month supplies reduces drug costs by a third
Purchasing prescription drugs in a three-month supply rather than a one-month supply has long been regarded as a way to reduce the cost of drugs for patients and third-party payers. New research from the University of Chicago quantifies the savings for the first time.
New Down syndrome treatment suggested by Stanford/Packard study in mice
At birth, children with Down syndrome aren't developmentally delayed. But as they age, these kids fall behind. Memory deficits inherent in Down syndrome hinder learning, making it hard for the brain to collect experiences needed for normal cognitive development.
At-risk college students reduce HBP, anxiety, depression through Transcendental Meditation
The Transcendental Meditation technique may be an effective method to reduce blood pressure, anxiety, depression, and anger among at-risk college students, according to a new study to be published in the American Journal of Hypertension, December 2009.
Teens' mental health affects how long they stay in school, new study shows
Queen's University researcher Steven Lehrer has won a prestigious international award in recognition of his contributions to health economics.
Ethnic pride may boost African-American teens' mental health
Most adolescents who belong to an ethnic minority group wrestle not only with their self-esteem (like most teens), but also with identity issues unique to their ethnic group, such as dealing with social stigma. A new study tells us that young people's ethnic pride may affect their mental health.
Faulty body clock may make kids bipolar
Malfunctioning circadian clock genes may be responsible for bipolar disorder in children. Researchers writing in the open access journal BMC Psychiatry found four versions of the regulatory gene RORB that were associated with pediatric bipolar disorder.
Women with asthma feel worse
Women with asthma are more anxious, find it harder to sleep and are more tired during the day than their male counterparts, but nevertheless tend to be better at following their treatment.
Connection between depression and osteoporosis detailed by Hebrew University researchers
Research carried out among thousands of people has shown a clear connection between depression and a loss of bone mass, leading to osteoporosis and fractures.
More Depression Current Events and Depression News Articles
 |
The Mindful Way through Depression: Freeing Yourself from Chronic Unhappiness by Mark Williams (Author), John Teasdale (Author), Zindel Segal (Author), Jon Kabat-Zinn (Author) If you’ve ever struggled with depression, take heart. Mindfulness, a simple yet powerful way of paying attention to your most difficult emotions and life experiences, can help you break the cycle of chronic unhappiness once and for all. In The Mindful Way through Depression, four uniquely qualified experts explain why our usual attempts to “think” our way out of a bad mood or just “snap out of it” lead us deeper into the downward spiral. Through insightful lessons drawn from both Eastern meditative traditions and cognitive therapy, they demonstrate how to sidestep the mental habits that lead to despair, including rumination and self-blame, so you can face life’s challenges with greater resilience. Jon Kabat-Zinn gently and encouragingly narrates the accompanying CD of guided... |
 |
The Cognitive Behavioral Workbook for Depression: A Step-by-step Program (Workbook) by William J. Knaus (Author), Albert Ellis (Foreword) In the 1950s, Albert Ellis pioneered a form of psychotherapy that combined ways of detecting and changing irrational thoughts with techniques for replacing negative behaviors with positive ones. This type of cognitive behavioral therapy, called rational emotive behavior therapy (REBT) by Ellis, proved especially effective at relieving problems like anger, anxiety, and depression. In this book author William Knaus, a close associate of Ellis, develops the best REBT techniques into a powerful and comprehensive self-help workbook for the treatment of depression. Following in New Harbinger’s tradition, this workbook is written in an easy-to-use, step-by-step format. It offers you powerful strategies for overcoming depression in simple, direct language, amply illustrated with stories... |
 |
Talking to Depression: Simple Ways To Connect When Someone In Your Life Is Depressed by Claudia J. Strauss (Author), Martha Manning (Foreword) When someone suffers from depression, friends and family members naturally want to help-but too often their good intentions come out all wrong. This practical, compassionate guide helps readers understand exactly what their loved one is going through, and why certain approaches help and others have the potential to do damage. Talking to Depression offers specific advice on what to do and what not to do-and what to say and what not to say-to avoid frustration and give the kind of caring, effective support that will make a difference. |
 |
Self-Coaching: The Powerful Program to Beat Anxiety and Depression, 2nd Edition, Completely Revised and Updated by Joseph J. Luciani (Author) The simple, untold truth about anxiety and depression is that they are habits of insecurity—and, like all habits, they can be broken. In this new edition of the highly successful Self-Coaching, Dr. Joseph Luciani shows you how to change your way of thinking and develop a healthy, adaptive way of living through his proven Self-Talk strategy for coaching yourself back to health. |
 |
Undoing Depression by Richard O'Connor (Author) For some people, depression has been a part of their experience for so long that they've begun to believe it's what they are. They become experts at "doing" depression--hiding it, working around it, even achieving great things (but at the price of great struggle, and little satisfaction). In this book, psychotherapist Richard O'Conner shows us how to "undo" depression, by replacing depressive patterns of thinking, relating, and behaving with a new and more effective set of skills. With a truly holistic approach that synthesizes the best of the many schools of thought about this painful disease, O'Conner offers new hope--and new life--for depressives. |
 |
Amoryn Depression Anxiety Relief (60 Caps) by BioNeurix AMORYN works by increasing the levels of all four of the brain's "feel good" neurotransmitters. By providing an all-natural boost to serotonin, dopamine, norepinephrine, and GABA, the ingredients in AMORYN can help you feel happy, calm, and confident.serotonin levels. As a precursor to serotonin, 5-HTP provides the brain with the "building blocks" needed to produce more serotonin naturally. |
 |
Overcoming Depression One Step at a Time: The New Behavioral Activation Approach to Getting Your Life Back (New Harbinger Self-Help Workbook) by Michael E., Ph.D. Addis (Author), Christopher R. Martell (Author) Learn breakthrough self-activation techniques to: ·Become more engaged with your life ·Enjoy daily activities ·Feel able to face challenges ·Stop avoiding social situations ·Feel strong and competent again ·Conquer the obstacles that keep depression going ·Stop making decisions based on your moods ·Get back on track with your life goals ·Recognize the habits and patterns that fuel your depression Achieve medication-free recovery Behavioral activation therapy offers effective, fast relief from depression. This powerful and progressive therapy steers away from the idea that depression symptoms represent an illness or weakness. Instead, depression is merely a signpost pointing directly at the things that need to change in one's life. Its engaging... |
 |
Depression: Out of the Shadows Many Americans are keeping an important, possibly deadly secret: depression. Approximately 15 million American adults live with this devastating disease which affects all age, race, gender, and socioeconomic groups. Through the voices and stories of people living with depression and interviews with scientists, Depression: Out of the Shadows provides a portrait of the disease never before seen on American television. |
 |
Depression: A Stubborn Darkness--Light for the Path (VantagePoint Books) by Edward T. Welch (Author) Depression: A Stubborn Darkness is Dr. Edward T. Welch's latest release in a series of ground-breaking best-selling counseling books that include When People Are Big and God is Small, Blame It on the Brain?, Addictions: A Banquet in the Grave. Now in its third printing, Welch continues to further his reputation as an author who can speak to general consumers in a language they intuitively connect with on a deeply personal level. Endorsed by Joni Eareckson Tada, and Bob Lepine of FamilyLife, this book is targeted to the 18 million adult Americans who struggle with depression. Compassionate and compelling, the book lays out issues and answers with Welch's world view that faith needs to be interlaced with therapies and medication for conditions categorized as strictly clinical. The author... |
 |
Depression Fallout: The Impact of Depression on Couples and What You Can Do to Preserve the Bond by Anne Sheffield (Author) What happens to love when a partner is depressed? Is your partner's depression undermining your happiness as a couple? After blaming yourself, losing your self-esteem, and getting angry, you may feel like walking away -- even if you're still in love. With 19 million Americans suffering from depression, you are not alone in your unhappiness. And no one knows what you're going through better than Anne Sheffield, who coined the phrase "depression fallout" in her first book, How You Can Survive When They're Depressed, to describe the emotional toll of depression on spouses, parents, lovers, and children.Sharing essential information, compassion, and street-smart advice, Anne Sheffield tells you: What you need to know about your partner's mental health and what to do about... |
| © 2009 BrightSurf.com |